Sign up to save your podcasts
Or
Share Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.
View all episodes
By American Academy of Neurology
4.6
2121 ratings
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.
More shows like Neurology Today in 5
View all
Radiolab
43,977 Listeners
Neurology® Podcast
302 Listeners
American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
26 Listeners
JNNP Podcast
9 Listeners
Practical Neurology Podcast
55 Listeners
Pod Save America
87,896 Listeners
Interesting Times with Ross Douthat
7,291 Listeners
Neurology Minute
137 Listeners
MDS Podcast
10 Listeners
The Lancet Neurology in conversation with
6 Listeners
The Ezra Klein Show
16,447 Listeners
Stroke Alert
39 Listeners
The Weekly Show with Jon Stewart
10,904 Listeners
Inner Cosmos with David Eagleman
599 Listeners
Continuum Audio
82 Listeners